Cryptococcosis

Hunter's Tropical Medicine and Emerging Infectious Disease: Ninth Edition

Volumn , Issue , 2012, Pages 641-643

  Dromer, Françoise ^a   Lortholary, Olivier ^b  

^a INSTITUT PASTEUR   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84902061392     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4390-4.00084-9     Document Type: Chapter

References (19)

1. Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. Aids 2009, 23:525-530.
2. McCarthy KM, Morgan J, Wannemuehler KA, et al. Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence. Aids 2006, 20:2199-2206.
3. Micol R, Lortholary O, Sar B, et al. Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients. J Acquir Immune Defic Syndr 2007, 45:555-559.
4. Mirza SA, Phelan M, Rimland D, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003, 36:789-794.
5. Lortholary O, Poizat G, Zeller V, et al. Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy. Aids 2006, 20:2183-2191.
6. Mitchell TG, Perfect JR Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995, 8:515-548.
7. Abadi J, Nachman S, Kressel AB, Pirofski L-A Cryptococcosis in children with AIDS. Clin Infect Dis 1999, 28:309-313.
8. Casadevall A, Perfect JR Cryptococcus neoformans 1998, American Society for Microbiology, Washington.
9. Lindberg J, Hagen F, Laursen A, et al. Cryptococcus gattii risk for tourists visiting Vancouver Island, Canada. Emerg Infect Dis 2007, 13:178-179.
10. Bicanic T, Meintjes G, Rebe K, et al. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J Acquir Immune Defic Syndr 2009, 51:130-134.
11. Lortholary O, Fontanet A, Memain N, et al. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. Aids 2005, 19:1043-1049.
12. Dromer F, Mathoulin-Pelissier S, Launay O, Lortholary O Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study. PLoS medicine 2007, 4:e21.
13. Graybill JR, Sobel J, Saag M, et al. the NIAID Mycoses Study Group and AIDS Cooperative treatment Groups. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis 2000, 30:47-54.
14. Bicanic T, Brouwer AE, Meintjes G, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. Aids 2009, 23:701-706.
15. Lortholary O, Nunez H, Brauner M, Dromer F Pulmonary cryptococcosis. Sem Resp Crit Care Med 2004, 25:145-157.
16. Chen S, Sorrell T, Nimmo G, et al. the Australasian Cryptococcal Study Group. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis 2000, 31:499-508.
17. Jarvis JN, Dromer F, Harrison TS, Lortholary O Managing cryptococcosis in the immunocompromised host. Curr Opin Infect Dis 2008, 21:596-603.
18. French N, Gray K, Watera C, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. Aids 2002, 16:1031-1038.
19. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:291-322.